AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36104745 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (75 mg twice per day) + agomelatine (25 mg per night)
Number of subjects: 46
Study 33619823 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine third-trimester ultrasound
Number of subjects: 508
Study 33619823 — intervention group
Group type: COMPARATOR
Intervention: Selective ultrasound based on serial SFH measurements (standard care)
Number of subjects: 508
Study 32029262 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 0.5 μg kg‐1
Number of subjects: 48
Study 32029262 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 1.0 μg kg‐1
Number of subjects: 48
Study 32029262 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 1.5 μg kg‐1
Number of subjects: 48
Study 32029262 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 2.0 μg kg‐1
Number of subjects: 48
Study 32029262 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine (all doses)
Number of subjects: 48
Study 32029262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 36270561 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefecon (16 mg/d)
Number of subjects: 199
Study 36270561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study 34972191 — intervention group
Group type: EXPERIMENTAL
Intervention: High granzyme B (GZMB) expression
Number of subjects: 1062
Study 34972191 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic signature capturing stromal, proliferative and immune functions
Number of subjects: 1062
Study 34972191 — intervention group
Group type: EXPERIMENTAL
Intervention: GZMB expression in CMS2 tumor cells
Number of subjects: 1062
Study 36309040 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent Transition Package (ATP)
Number of subjects: 1066
Study 36309040 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care practice (Control)
Number of subjects: 1066
Study 33600826 — intervention group
Group type: EXPERIMENTAL
Intervention: PACAP38
Number of subjects: 35
Study 33600826 — intervention group
Group type: COMPARATOR
Intervention: Sumatriptan
Number of subjects: 35
Study 36343893 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg mocravimod/day
Number of subjects: 0
Study 36343893 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg mocravimod/day
Number of subjects: 0
Study 36343893 — intervention group
Group type: COMPARATOR
Intervention: Standard of care GvHD prophylaxis (cyclosporine A/methotrexate or tacrolimus/methotrexate)
Number of subjects: 0
Study 33107329 — intervention group
Group type: EXPERIMENTAL
Intervention: Binaural beats (DCG-1 and USRG-1)
Number of subjects: 411
Study 33107329 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music (DCG-2 and USRG-2)
Number of subjects: 411
Study 33107329 — intervention group
Group type: COMPARATOR
Intervention: Control (DCG-3 and USRG-3)
Number of subjects: 411
Study 32240892 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Initiated Follow Up (PIFU)
Number of subjects: 44
Study 32240892 — intervention group
Group type: COMPARATOR
Intervention: Routine CA125 surveillance
Number of subjects: 44
Study 32240892 — intervention group
Group type: COMPARATOR
Intervention: Cervical or vault cytology
Number of subjects: 44
Study 32240892 — intervention group
Group type: COMPARATOR
Intervention: Telephone follow up
Number of subjects: 44
Study 32240892 — intervention group
Group type: COMPARATOR
Intervention: Nurse led follow up
Number of subjects: 44
Study 33745962 — intervention group
Group type: EXPERIMENTAL
Intervention: Invisible support from a stranger
Number of subjects: 138
Study 33745962 — intervention group
Group type: COMPARATOR
Intervention: No support
Number of subjects: 138
Study 35306633 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive education intervention (IG) with repeated, structured multimodal education on correct injection techniques.
Number of subjects: 713
Study 35306633 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) with a single educational session.
Number of subjects: 713
Study 32658253 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanabecestat 20mg
Number of subjects: 0
Study 32658253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36007870 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma (CP) therapy (300mL)
Number of subjects: 421
Study 34536266 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic transtympanic cartilage myringoplasty with removal of perforation edges (n=39)
Number of subjects: 79
Study 34536266 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic transtympanic cartilage myringoplasty with preservation of perforation edges (n=40)
Number of subjects: 79
Study 34193647 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional steroids
Number of subjects: 36
Study 34193647 — intervention group
Group type: COMPARATOR
Intervention: Systemic steroids
Number of subjects: 36
Study 33568003 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based exercises (stationary running, frontal kick, butt kick) at cadences of 80 b·min‐1, 100 b·min‐1, and maximal
Number of subjects: 10
Study 33568003 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal cadence
Number of subjects: 10
Study 33568003 — intervention group
Group type: COMPARATOR
Intervention: Land-based exercises (stationary running, frontal kick, butt kick)
Number of subjects: 10
Study 32683489 — intervention group
Group type: EXPERIMENTAL
Intervention: HYPO (normobaric hypoxia with FiO2 set to 13.5%) during post-exercise muscle ischemia (PEMI)
Number of subjects: 11
Study 32683489 — intervention group
Group type: EXPERIMENTAL
Intervention: NORMO (normoxia) during post-exercise muscle ischemia (PEMI)
Number of subjects: 11
Study 32683489 — intervention group
Group type: COMPARATOR
Intervention: HYPO (normobaric hypoxia with FiO2 set to 13.5%) during control exercise recovery session
Number of subjects: 11
Study 32683489 — intervention group
Group type: COMPARATOR
Intervention: NORMO (normoxia) during control exercise recovery session
Number of subjects: 11
Study 34933665 — intervention group
Group type: EXPERIMENTAL
Intervention: Social work case management intervention
Number of subjects: 169
Study 34933665 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 169
Study 33346499 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency renal artery denervation (RND)
Number of subjects: 0
Study 35821110 — intervention group
Group type: EXPERIMENTAL
Intervention: VR training group (n = 10)
Number of subjects: 20
Study 35821110 — intervention group
Group type: COMPARATOR
Intervention: SG group (n = 10)
Number of subjects: 20
Study 33683643 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy Healing (EH) therapy with three sessions
Number of subjects: 50
Study 33683643 — intervention group
Group type: COMPARATOR
Intervention: Standard operative care (Control)
Number of subjects: 50
Study 33683643 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy Healing (EH) therapy
Number of subjects: 50
Study 33095199 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet weather conditions
Number of subjects: 0
Study 33095199 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted wave action sites
Number of subjects: 0
Study 33095199 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin resistance
Number of subjects: 0
Study 33095199 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum inhibitory concentration testing
Number of subjects: 0
Study 33095199 — intervention group
Group type: COMPARATOR
Intervention: Non-restricted wave action sites
Number of subjects: 0
Study 35688036 — intervention group
Group type: EXPERIMENTAL
Intervention: BS self-etching sealant (BeautiSealant-Shofu)
Number of subjects: 28
Study 35688036 — intervention group
Group type: COMPARATOR
Intervention: FS conventional sealant (Fluoroshield-Dentsply)
Number of subjects: 28
Study 33973384 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5-10 mg every 8 weeks
Number of subjects: 1840
Study 33973384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1840
Study 33973384 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 5 mg
Number of subjects: 1840
Study 33973384 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab (5.9-7.0%)
Number of subjects: 1840
Study 33973384 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5-10 mg
Number of subjects: 1840
Study 33973384 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanezumab 2.5-5 mg
Number of subjects: 1840
Study 34690287 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-leg knee extension (SLKE) training (n = 12)
Number of subjects: 36
Study 34690287 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive stretching training (PST) (n = 12)
Number of subjects: 36
Study 34690287 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention) (n = 12)
Number of subjects: 36
Study 34677609 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current brain stimulation (tDCS; 2 mA) for 20 minutes before chemotherapy
Number of subjects: 60
Study 34677609 — intervention group
Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 60
Study 32128971 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttransplant exercise
Number of subjects: 0
Study 32128971 — intervention group
Group type: COMPARATOR
Intervention: Exercise
Number of subjects: 0
Study 35101271 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVI
Number of subjects: 138
Study 35101271 — intervention group
Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 138
Study 35101271 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVI and SAVR
Number of subjects: 138
Study 32949673 — intervention group
Group type: EXPERIMENTAL
Intervention: Aversive motivational state
Number of subjects: 102
Study 32949673 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study 32949673 — intervention group
Group type: EXPERIMENTAL
Intervention: Appetitive motivational state
Number of subjects: 102
Study 35354637 — intervention group
Group type: EXPERIMENTAL
Intervention: BP self-monitoring and tele-monitoring plus a free SPC-based telemedicine titration therapy for 6 months
Number of subjects: 358
Study 35354637 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring BP without any therapy change
Number of subjects: 358
Study 35175066 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose alcohol condition (BrAC = .04%)
Number of subjects: 313
Study 35175066 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose alcohol condition (BrAC = .08%)
Number of subjects: 313
Study 35175066 — intervention group
Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 313
Study 35175066 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 313
Study 32568433 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion (0.5 µg/kg/min)
Number of subjects: 53
Study 32568433 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 35270330 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Video Games (AVG) intervention combined with multicomponent exercise, 5 months, 3 sessions per week
Number of subjects: 29
Study 35270330 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) continued daily activities without modification
Number of subjects: 29
Study 33752609 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer leader diabetes self-management support (PLDSMS) intervention
Number of subjects: 0
Study 32749942 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg twice daily)
Number of subjects: 0
Study 36226043 — intervention group
Group type: EXPERIMENTAL
Intervention: ECCE Malaysian government policy education
Number of subjects: 629
Study 36226043 — intervention group
Group type: EXPERIMENTAL
Intervention: Government education on ECCE
Number of subjects: 629
Study 36226043 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group interviews
Number of subjects: 629
Study 36226043 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement of ECCE policies
Number of subjects: 629
Study 32223444 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 4614
Study 32223444 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 4614
Study 32223444 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K Antagonist (VKA)
Number of subjects: 4614
Study 32223444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4614
Study 35724840 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured transition program delivered over 15 months
Number of subjects: 156
Study 35724840 — intervention group
Group type: COMPARATOR
Intervention: Usual care from the pediatric site
Number of subjects: 156
Study 34282949 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted Lp(a) levels
Number of subjects: 908087
Study 34282949 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization-phenome-wide association analyses
Number of subjects: 908087
Study 35883115 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behaviour therapy (CBT) for 10 weeks
Number of subjects: 90
Study 35883115 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 90
Study 35883115 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behaviour therapy (CBT)
Number of subjects: 90
Study 33417105 — intervention group
Group type: EXPERIMENTAL
Intervention: Fathers present in the household
Number of subjects: 2533
Study 33417105 — intervention group
Group type: COMPARATOR
Intervention: Fathers deceased and adult males absent
Number of subjects: 2533
Study 33417105 — intervention group
Group type: EXPERIMENTAL
Intervention: Fathers deceased but other adult males present
Number of subjects: 2533
Study 32317000 — intervention group
Group type: EXPERIMENTAL
Intervention: SALTCHECKER (with a smart salt checker and a salt-limiting WeChat mini programme)
Number of subjects: 0
Study 32317000 — intervention group
Group type: COMPARATOR
Intervention: Salt checker (with only a weighing function)
Number of subjects: 0
Study 36153481 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored Facebook banner ads
Number of subjects: 0
Study 36153481 — intervention group
Group type: COMPARATOR
Intervention: Non-tailored Facebook banner ads
Number of subjects: 0
Study 33565715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation (4000 IU daily)
Number of subjects: 193
Study 33565715 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study 33565715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation
Number of subjects: 193
Study 33095774 — intervention group
Group type: EXPERIMENTAL
Intervention: Online feedback during practice (group 2, 3, and 4)
Number of subjects: 44
Study 33095774 — intervention group
Group type: COMPARATOR
Intervention: No feedback during practice (group 1, control)
Number of subjects: 44
Study 33095774 — intervention group
Group type: EXPERIMENTAL
Intervention: Target coordination = 180° (group 4)
Number of subjects: 44
Study 33095774 — intervention group
Group type: EXPERIMENTAL
Intervention: Target coordination = 0° (group 2)
Number of subjects: 44
Study 33095774 — intervention group
Group type: EXPERIMENTAL
Intervention: Target coordination = 90° (group 3)
Number of subjects: 44
Study 33095774 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous coordination
Number of subjects: 44
Study 35943205 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trial (RCT)
Number of subjects: 0
Study 35943205 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural Experiment
Number of subjects: 0
Study 33976543 — intervention group
Group type: EXPERIMENTAL
Intervention: umeclidinium/vilanterol
Number of subjects: 2425
Study 33976543 — intervention group
Group type: COMPARATOR
Intervention: umeclidinium
Number of subjects: 2425
Study 33976543 — intervention group
Group type: COMPARATOR
Intervention: salmeterol
Number of subjects: 2425
Study 33976543 — intervention group
Group type: EXPERIMENTAL
Intervention: CII at Week 4
Number of subjects: 2425
Study 33976543 — intervention group
Group type: EXPERIMENTAL
Intervention: No CII at Week 4
Number of subjects: 2425
Study 32073316 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin C (1,500 mg per day in three divided doses) from the first postoperative day
Number of subjects: 400
Study 32073316 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative medications with placebo
Number of subjects: 400
Study 36262834 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular plaster therapy (APT)
Number of subjects: 44
Study 36262834 — intervention group
Group type: COMPARATOR
Intervention: Sham auricular plaster therapy
Number of subjects: 44
Study 32128593 — intervention group
Group type: EXPERIMENTAL
Intervention: dCBT
Number of subjects: 410
Study 32128593 — intervention group
Group type: COMPARATOR
Intervention: wait-list control
Number of subjects: 410
Study 34407547 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord blood (UCB)
Number of subjects: 80
Study 33832661 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary Mitral Regurgitation (SMR)
Number of subjects: 106
Study 33832661 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Mitral Regurgitation (PMR)
Number of subjects: 106
Study 33832661 — intervention group
Group type: COMPARATOR
Intervention: Normal Valves
Number of subjects: 106
Study 36207981 — intervention group
Group type: COMPARATOR
Intervention: Steatotic donor liver group (n=81)
Number of subjects: 814
Study 36207981 — intervention group
Group type: COMPARATOR
Intervention: Mild and moderate steatosis groups (n=81)
Number of subjects: 814
Study 34696820 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-supporting intervention delivered by dermatology nurses
Number of subjects: 114
Study 34696820 — intervention group
Group type: COMPARATOR
Intervention: Standard procedure (non-intervention)
Number of subjects: 114
Study 33022197 — intervention group
Group type: EXPERIMENTAL
Intervention: SKNB19 (twice a day application)
Number of subjects: 18
Study 33022197 — intervention group
Group type: COMPARATOR
Intervention: HQ4% (nightly application)
Number of subjects: 18
Study 36266615 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-aided rowing exercise (CRE)
Number of subjects: 38
Study 34416023 — intervention group
Group type: EXPERIMENTAL
Intervention: Romiplostim
Number of subjects: 0
Study 34416023 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-Care (SOC)
Number of subjects: 0
Study 33810414 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Protein (HP) diet
Number of subjects: 35
Study 33810414 — intervention group
Group type: COMPARATOR
Intervention: Low Glycemic Index (LGI) diet
Number of subjects: 35
Study 32019482 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Turf (AT)
Number of subjects: 18
Study 32019482 — intervention group
Group type: COMPARATOR
Intervention: Natural Turf (NT)
Number of subjects: 18
Study 35430494 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and contact group
Number of subjects: 121
Study 35430494 — intervention group
Group type: COMPARATOR
Intervention: Education only group
Number of subjects: 121
Study 33523474 — intervention group
Group type: EXPERIMENTAL
Intervention: RO7049389
Number of subjects: 0
Study 32103298 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 35727626 — intervention group
Group type: EXPERIMENTAL
Intervention: Unguided IBI using cognitive behavior therapy
Number of subjects: 145
Study 35727626 — intervention group
Group type: EXPERIMENTAL
Intervention: Text support condition (asynchronous clinician support through text)
Number of subjects: 145
Study 35727626 — intervention group
Group type: EXPERIMENTAL
Intervention: Video support condition (asynchronous clinician support through video)
Number of subjects: 145
Study 35727626 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided IBI (text and video support)
Number of subjects: 145
Study 32032740 — intervention group
Group type: EXPERIMENTAL
Intervention: FAM21 (21 sessions of focused attention meditation)
Number of subjects: 29
Study 32032740 — intervention group
Group type: EXPERIMENTAL
Intervention: FAM1 (single session of focused attention meditation)
Number of subjects: 29
Study 32032740 — intervention group
Group type: COMPARATOR
Intervention: Control (no preceding FAM)
Number of subjects: 29
Study 35320361 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 μg dasiglucagon
Number of subjects: 10
Study 35320361 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 μg dasiglucagon
Number of subjects: 10
Study 35320361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 32347302 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampal-sparing whole brain irradiation with simultaneous integrated boost (HSIB-WBRT)
Number of subjects: 50
Study 34415795 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lotilaner ophthalmic solution, 0.25%, treated bid for 42 days
Number of subjects: 18
Study 32397113 — intervention group
Group type: EXPERIMENTAL
Intervention: lenalidomide
Number of subjects: 56
Study 34326044 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led non-pharmacological intervention
Number of subjects: 18
Study 33814901 — intervention group
Group type: EXPERIMENTAL
Intervention: Oronasal mask
Number of subjects: 30
Study 33814901 — intervention group
Group type: COMPARATOR
Intervention: Nasal mask
Number of subjects: 30
Study 32275032 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 120 mg
Number of subjects: 0
Study 32275032 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 4 g
Number of subjects: 0
Study 32275032 — intervention group
Group type: COMPARATOR
Intervention: Morphine 20 mg
Number of subjects: 0
Study 36181047 — intervention group
Group type: EXPERIMENTAL
Intervention: XGBoost model with variables related to intravenous (IV) fluid management and electrolytes
Number of subjects: 1185
Study 36181047 — intervention group
Group type: COMPARATOR
Intervention: XGBoost model without variables related to IV fluid management and electrolytes
Number of subjects: 1185
Study 34044245 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily antioxidant supplement comprising polyphenols, omega‐3 fatty acids, vitamin E, and selenium
Number of subjects: 20
Study 34044245 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antioxidant supplementation)
Number of subjects: 20